CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.

Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), founded in 1997, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd. (stock code: 000661.SZ). GenSci stands out as the only manufacturer to have three generations of recombinant human growth hormone (rhGH) worldwide, including Asia's first liquid formulation rhGH, Jintropin(®), and the world's first long-acting GH injection, Jintrolong(®). Over nearly three decades of development, GenSci has established deep expertise in pediatric and women's health, and emerges as a leader in biopharmaceuticals and innovative drug development including therapeutic areas of endocrinology & metabolism, immunology & respiratory diseases, and oncology.